The results demonstrated that TGFβR2 expression levels were significantly higher in NSCLC tumor biopsies (2.46 ± 0.42) relative to adjacent non-neoplastic tissues (1.01 ± 0.06). The gene discussed is TGFBR2; the disease is neoplasm.